DEFIBROTIDE SODIUM
UNII L7CHH2B2J0

Substance Identification & Data

This profile provides standardized clinical and technical data for Defibrotide Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L7CHH2B2J0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 83712-60-1 and the RxNorm Concept ID (RxCUI) 1311089. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L7CHH2B2J0

CAS Registry Number

83712-60-1

RxNorm Concept ID

1311089

Detailed Substance Profile

Preferred Name

DEFIBROTIDE SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

L7CHH2B2J0

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C1064

National Cancer Institute reference terminology for clinical and research data.

INN ID

4876

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-32

Identifier assigned by the United States Adopted Names Council.

Substance Type

polymer

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Defibrotide Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.